2.Dysregulated MicroRNA Expression in Irritable Bowel Syndrome.
Journal of Neurogastroenterology and Motility 2016;22(2):166-167
No abstract available.
Irritable Bowel Syndrome*
;
MicroRNAs*
3.Reply: The Characteristics about Our Study in Irritable Bowel Syndrome.
Kang Min ZHUANG ; Yu Bin GUO ; Si De LIU
Gut and Liver 2017;11(1):168-168
No abstract available.
Irritable Bowel Syndrome*
4.Pathogenesis of Irritable Bowel Syndrome: Is It Really in the Gene?.
Journal of Neurogastroenterology and Motility 2014;20(3):284-286
No abstract available.
Irritable Bowel Syndrome*
5.Is Rome III Criteria for Irritable Bowel Syndrome More Useful Than Rome II Criteria in Korea?: Author's Reply.
Journal of Neurogastroenterology and Motility 2010;16(3):343-344
No abstract available.
Irritable Bowel Syndrome
;
Rome
6.Is Rome III Criteria for Irritable Bowel Syndrome More Useful Than Rome II Criteria in Korea?.
Journal of Neurogastroenterology and Motility 2010;16(3):342-342
No abstract available.
Irritable Bowel Syndrome
;
Rome
7.Long-term Prognosis of Postinfectious Irritable Bowel Syndrome (Gut 2010;59:605-611).
Journal of Neurogastroenterology and Motility 2010;16(3):337-338
No abstract available.
Irritable Bowel Syndrome
;
Prognosis
8.The psychological characteristics of patients with irritable bowel syndrome.
Sung Dong LEE ; Oh Su HAN ; Young Il MIN
Journal of Korean Neuropsychiatric Association 1993;32(2):202-211
No abstract available.
Humans
;
Irritable Bowel Syndrome*
9.Irritable Bowel Syndrome.
Journal of the Korean Medical Association 1999;42(9):843-853
No abstract available.
Irritable Bowel Syndrome*
10.Comments on Tegaserod Trial on Irritable Bowel Syndrome.
Journal of Neurogastroenterology and Motility 2010;16(2):222-222
No abstract available.
Indoles
;
Irritable Bowel Syndrome